Comprehensive Cardiovascular Profile 2.0 by Genova Diagnostics provides state of the art assessment of cardiovascular risk and response to treatment. Utilizing VAPâ„¢ lipid fractionazation technology, physicians can increase their detection of cardiovascular disease risk from 55% with standard lipid profiles to greater than 85% with this test. Inclusion of lipid-independent risk factors such as homocysteine, hs C-reactive protein, and fibrinogen provides effective means to assess methylation impairments, inflammation, and hemostatic factors that relate strongly to cardiovascular disease. Blood draw required at lab of your choice, small fee may apply. Doctors order provided. Not available to NY residents.
Dr. David Scheiderer MD, MBA, DFAPA, is the Chief Medical Officer and Director of Education at Integrative Psychiatry, Inc. in Sarasota, Florida and the President of Tiberius Enterprises, Inc. in Roanoke, Virginia. An accomplished clinician, educator, and lecturer, Dr. Dave has established himself as a key opinion leader in the fields of both mainstream psychiatry and functional medicine. Dissatisfied with the patient outcomes using only conventional treatments, he began treating his patients by addressing biological imbalances with lifestyle improvements, nutrition and nutraceuticals to get better outcomes. His integrative approach provided much improved results. Dr. Dave is passionate about helping the community he serves by personalizing treatments and educating the public about mental health and healthy aging. He has formulated several of our supplements and sat on the advisory board for many others, ensuring the products we carry are based on science and experience and have the best efficacy rates and highest ingredient quality available.